These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 22827500)

  • 1. Polyvalent dendrimer-methotrexate as a folate receptor-targeted cancer therapeutic.
    Thomas TP; Huang B; Choi SK; Silpe JE; Kotlyar A; Desai AM; Zong H; Gam J; Joice M; Baker JR
    Mol Pharm; 2012 Sep; 9(9):2669-2676. PubMed ID: 22827500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bifunctional PAMAM dendrimer conjugates of folic acid and methotrexate with defined ratio.
    Zong H; Thomas TP; Lee KH; Desai AM; Li MH; Kotlyar A; Zhang Y; Leroueil PR; Gam JJ; Banaszak Holl MM; Baker JR
    Biomacromolecules; 2012 Apr; 13(4):982-91. PubMed ID: 22360561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Folate Receptor-Targeted Dendrimer-Methotrexate Conjugate for Inflammatory Arthritis.
    Qi R; Majoros I; Misra AC; Koch AE; Campbell P; Marotte H; Bergin IL; Cao Z; Goonewardena S; Morry J; Zhang S; Beer M; Makidon P; Kotlyar A; Thomas TP; Baker JR
    J Biomed Nanotechnol; 2015 Aug; 11(8):1431-41. PubMed ID: 26295143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PSMA-targeted stably linked "dendrimer-glutamate urea-methotrexate" as a prostate cancer therapeutic.
    Huang B; Otis J; Joice M; Kotlyar A; Thomas TP
    Biomacromolecules; 2014 Mar; 15(3):915-23. PubMed ID: 24392665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preclinical antitumor efficacy evaluation of dendrimer-based methotrexate conjugates.
    Myc A; Douce TB; Ahuja N; Kotlyar A; Kukowska-Latallo J; Thomas TP; Baker JR
    Anticancer Drugs; 2008 Feb; 19(2):143-9. PubMed ID: 18176110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting and inhibition of cell growth by an engineered dendritic nanodevice.
    Thomas TP; Majoros IJ; Kotlyar A; Kukowska-Latallo JF; Bielinska A; Myc A; Baker JR
    J Med Chem; 2005 Jun; 48(11):3729-35. PubMed ID: 15916424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polyvalent saccharide-functionalized generation 3 poly(amidoamine) dendrimer-methotrexate conjugate as a potential anticancer agent.
    Zhang Y; Thomas TP; Lee KH; Li M; Zong H; Desai AM; Kotlyar A; Huang B; Holl MM; Baker JR
    Bioorg Med Chem; 2011 Apr; 19(8):2557-64. PubMed ID: 21459000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Avidity modulation of folate-targeted multivalent dendrimers for evaluating biophysical models of cancer targeting nanoparticles.
    Silpe JE; Sumit M; Thomas TP; Huang B; Kotlyar A; van Dongen MA; Banaszak Holl MM; Orr BG; Choi SK
    ACS Chem Biol; 2013 Sep; 8(9):2063-71. PubMed ID: 23855478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sequence-Defined Oligoamide Drug Conjugates of Pretubulysin and Methotrexate for Folate Receptor Targeted Cancer Therapy.
    Truebenbach I; Gorges J; Kuhn J; Kern S; Baratti E; Kazmaier U; Wagner E; Lächelt U
    Macromol Biosci; 2017 Oct; 17(10):. PubMed ID: 28371444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted dendrimeric anticancer prodrug: a methotrexate-folic acid-poly(amidoamine) conjugate and a novel, rapid, "one pot" synthetic approach.
    Zhang Y; Thomas TP; Desai A; Zong H; Leroueil PR; Majoros IJ; Baker JR
    Bioconjug Chem; 2010 Mar; 21(3):489-95. PubMed ID: 20128612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design considerations for PAMAM dendrimer therapeutics.
    Goonewardena SN; Kratz JD; Zong H; Desai AM; Tang S; Emery S; Baker JR; Huang B
    Bioorg Med Chem Lett; 2013 May; 23(10):2872-5. PubMed ID: 23583511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms and implications of dual-acting methotrexate in folate-targeted nanotherapeutic delivery.
    Wong PT; Choi SK
    Int J Mol Sci; 2015 Jan; 16(1):1772-90. PubMed ID: 25590303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Photochemical release of methotrexate from folate receptor-targeting PAMAM dendrimer nanoconjugate.
    Choi SK; Thomas TP; Li MH; Desai A; Kotlyar A; Baker JR
    Photochem Photobiol Sci; 2012 Apr; 11(4):653-60. PubMed ID: 22234658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Augmented anticancer activity of a targeted, intracellularly activatable, theranostic nanomedicine based on fluorescent and radiolabeled, methotrexate-folic Acid-multiwalled carbon nanotube conjugate.
    Das M; Datir SR; Singh RP; Jain S
    Mol Pharm; 2013 Jul; 10(7):2543-57. PubMed ID: 23683251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integration of phospholipid-hyaluronic acid-methotrexate nanocarrier assembly and amphiphilic drug-drug conjugate for synergistic targeted delivery and combinational tumor therapy.
    Li Y; Zhang H; Chen Y; Ma J; Lin J; Zhang Y; Fan Z; Su G; Xie L; Zhu X; Hou Z
    Biomater Sci; 2018 Jun; 6(7):1818-1833. PubMed ID: 29785434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Folate-targeted nanoparticles show efficacy in the treatment of inflammatory arthritis.
    Thomas TP; Goonewardena SN; Majoros IJ; Kotlyar A; Cao Z; Leroueil PR; Baker JR
    Arthritis Rheum; 2011 Sep; 63(9):2671-80. PubMed ID: 21618461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multifunctional mitoxantrone-conjugated magnetic nanosystem for targeted therapy of folate receptor-overexpressing malignant cells.
    Barar J; Kafil V; Majd MH; Barzegari A; Khani S; Johari-Ahar M; Asgari D; Coukos G; Omidi Y
    J Nanobiotechnology; 2015 Mar; 13():26. PubMed ID: 25880772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting the efficacy of a dendrimer-based nanotherapeutic in heterogeneous xenograft tumors in vivo.
    Myc A; Kukowska-Latallo J; Cao P; Swanson B; Battista J; Dunham T; Baker JR
    Anticancer Drugs; 2010 Feb; 21(2):186-92. PubMed ID: 20010426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methotrexate-gelonin conjugate - an inhibitor of MCF-7 cells expressing the dihydrofolate receptor.
    Badr M; Kopp C; Theison S; Meyer J; Trommer WE
    Biol Chem; 2014 Dec; 395(12):1461-6. PubMed ID: 25205711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activity of dendrimer-methotrexate conjugates on methotrexate-sensitive and -resistant cell lines.
    Gurdag S; Khandare J; Stapels S; Matherly LH; Kannan RM
    Bioconjug Chem; 2006; 17(2):275-83. PubMed ID: 16536456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.